Ocular Therapeutix, Inc. announced today that it has closed a $14 million Series D round of financing. The round was led by Ascension Health Ventures of St. Louis, Missouri, with continued participation by existing investors including Polaris Ventures,…
Ocular Therapeutix, Inc. Completes Series D Financing To Support Phase II Sustained Drug Delivery Clinical Trials
Ocular Therapeutix, Inc. announced today that it has closed a $14 million Series D round of financing. The round was led by Ascension Health Ventures of St. Louis, Missouri, with continued participation by existing investors including Polaris Ventures,…
Ocular Therapeutix, Inc. Completes Series D Financing To Support Phase II Sustained Drug Delivery Clinical Trials
Ocular Therapeutix, Inc. announced today that it has closed a $14 million Series D round of financing. The round was led by Ascension Health Ventures of St. Louis, Missouri, with continued participation by existing investors including Polaris Ventures,…
Apple Jupp Ltd: Are You Turning A Blind Eye To Contact Lenses Hygiene? Price Contact Lenses Launches Discount Contact Lens Hygiene Guide
Even if you’ve been wearing contact lenses all of your adult life, you’re sure to have fallen into a few bad habits. And unlike driver’s ed, there’s no refresher classes for making sure you’re treating your lenses with the respect they deserve…
Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
Status: Recruiting,
Condition Summary: Retinal Disease
5 Questions I. Howard Fine,MD
bWhat is your most memorable
experience in this industry?/bbr /My most memorable experiences in
ophthalmology have been delivering
both the Charles D. Kelman Innovator’s
Lecture and the Binkhorst Medal
Lecture at ASCRS meetings. These…